MEDICALM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICALM
Largest movements
- Cash +€738
up €738 (+5.9%), from €12,535 to €13,273
mainly Other debts (+€4,398) and Depreciation (+€399)
- Tangible fixed assets -€399
down €399 (-25.0%), from €1,597 to €1,198
- Other debts +€4,398
up €4,398 (+156%), from €2,819 to €7,217
- Profit (loss) carried forward -€3,820
down €3,820 (-33.9%), from €11,277 to €7,457
- Tax, wage and social debts -€500
down €500 (-33.3%), from €1,500 to €1,000
- Trade debts +€244
up €244 (+4,067%), from €6 to €250
- Other operating charges -€465
down €465 (-53.3%), from €872 to €407
- Depreciation -€236
down €236 (-37.1%), from €635 to €399
- Financial charges -€200
down €200 (-54.0%), from €370 to €170
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €17,252 | €17,574 | +€322 | +1.9% |
| Fixed assets | 21/28 | €4,502 | €4,103 | -€399 | -8.9% |
| Tangible fixed assets | 22/27 | €1,597 | €1,198 | -€399 | -25.0% |
| Other tangible fixed assets | 26 | €1,597 | €1,198 | -€399 | -25.0% |
| Financial fixed assets | 28 | €2,905 | €2,905 | = | 0.0% |
| Current assets | 29/58 | €12,750 | €13,471 | +€721 | +5.7% |
| Cash at bank and in hand | 54/58 | €12,535 | €13,273 | +€738 | +5.9% |
| Deferred charges and accrued income | 490/1 | €215 | €198 | -€17 | -7.9% |
| Total equity and liabilities | 10/49 | €17,252 | €17,574 | +€322 | +1.9% |
| Equity | 10/15 | €12,927 | €9,107 | -€3,820 | -29.6% |
| Contributions | 10/11 | €1,500 | €1,500 | = | 0.0% |
| Contributions outside capital | 11 | €1,500 | €1,500 | = | 0.0% |
| Other | 1109/19 | €1,500 | €1,500 | = | 0.0% |
| Reserves | 13 | €150 | €150 | = | 0.0% |
| Non-distributable reserves | 130/1 | €150 | €150 | = | 0.0% |
| Reserves not available under the articles | 1311 | €150 | €150 | = | 0.0% |
| Profit (loss) carried forward | 14 | €11,277 | €7,457 | -€3,820 | -33.9% |
| Amounts payable | 17/49 | €4,325 | €8,467 | +€4,142 | +95.8% |
| Amounts payable within one year | 42/48 | €4,325 | €8,467 | +€4,142 | +95.8% |
| Trade debts | 44 | €6 | €250 | +€244 | +4,067% |
| Suppliers | 440/4 | €6 | €250 | +€244 | +4,067% |
| Taxes, remuneration and social security | 45 | €1,500 | €1,000 | -€500 | -33.3% |
| Taxes | 450/3 | €1,500 | €1,000 | -€500 | -33.3% |
| Other amounts payable | 47/48 | €2,819 | €7,217 | +€4,398 | +156% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €635 | €399 | -€236 | -37.1% |
| Other operating charges | 640/8 | €872 | €407 | -€465 | -53.3% |
| Gross operating margin | 9900 | -€2,819 | -€2,844 | -€25 | -0.9% |
| Operating profit (loss) | 9901 | -€4,326 | -€3,650 | +€676 | +15.6% |
| Financial charges | 65/66B | €370 | €170 | -€200 | -54.0% |
| Recurring financial charges | 65 | €370 | €170 | -€200 | -54.0% |
| Profit (loss) for the period before taxes | 9903 | -€4,696 | -€3,820 | +€876 | +18.6% |
| Profit (loss) for the period | 9904 | -€4,696 | -€3,820 | +€876 | +18.6% |
| Profit (loss) for the period to be appropriated | 9905 | -€4,696 | -€3,820 | +€876 | +18.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.